Clinical artificial intelligence platform Healthleap raised $38 million in combined seed and series A funding to expand its platform to more conditions.
Sequoia Capital, First Round Capital and Hummingbird Ventures participated in the funding rounds.
Healthleap was founded by siblings Josiah and Jemima Meyer, who teamed up after Jemima, as a clinician, started building tools to help herself and colleagues treat patients faster, according to the company.
Launched in 2022, Healthleap aids hospitals in identifying undiagnosed conditions across inpatient and outpatient care settings. The company says its platform continuously analyzes every patient’s record, including notes, labs, vitals, orders, problem lists and flags risk for conditions. Healthleap then pushes actionable risk scores into optimized electronic health record workflows to support clinicians in identifying, treating and improving their patients’ health.
“We were immediately drawn to Healthleap’s bold vision: imagine if every hospital could use real-time AI to spot overlooked clinical risk, improve patient care, and unlock meaningful reimbursement revenue,” said Josh Kopelman, First Round Capital co-founder and partner, in a statement. “That’s exactly what Healthleap is delivering and more, starting with disease-related malnutrition and rapidly expanding across conditions to save lives and hospitals money.”
Healthleap has initially focused on disease-related malnutrition, a condition that costs the U.S. healthcare system up to $58 billion annually. The company says it is the first and only validated AI malnutrition screening tool that contains EHR-integrated screening layers.
Most hospitals still screen for malnutrition with two questions that a nurse asks once, at admission. Patients who are sedated, confused or too sick to answer are the ones most likely to be missed. Up to half of hospitalized patients are at risk, according to a study, yet fewer than 9% are formally diagnosed, contributing to increased morbidity, mortality, length of hospital stay and cost.
One Penn Medicine hospital observed that Healthleap drove $23.8 million a year from a combination of incremental reimbursement revenue and the financial impact of length-of-stay reductions.
“Healthleap is focused on finding patients who are being missed and getting them the care they need,” said Alfred Lin, Sequoia Capital partner, in a statement. “The impact for both patients and hospitals has been inspiring, with one hospital seeing 39% more malnutrition cases identified and treated, and $11 million in incremental revenue in a single health system.”
Josiah Meyer, Healthleap's CEO, told Fierce Healthcare the company plans to use the fresh capital to expand "beyond malnutrition to more than 40 conditions," adding that targeted expansion areas include delirium, aspiration pneumonia and pressure injuries.
“We also plan to hire across engineering, sales, customer success, and product,” Meyer said. “This hiring will let us bring our platform to hundreds of hospitals in the coming year.”
In late June, Houston Methodist announced a system-wide launch of the platform.